Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.
Monzo M, Brunet S, Urbano-Ispizua A, Navarro A, Perea G, Esteve J, Artells R, Granell M, Berlanga J, Ribera JM, Bueno J, Llorente A, Guardia R, Tormo M, Torres P, Nomdedéu JF, Montserrat E, Sierra J; CETLAM.
Monzo M, et al. Among authors: artells r.
Blood. 2006 Jun 15;107(12):4871-9. doi: 10.1182/blood-2005-08-3272. Epub 2006 Feb 28.
Blood. 2006.
PMID: 16507781
Free article.
Clinical Trial.